Clinical Analysis of Endovascular Treatment of TASC (Ⅱ) D-Type Femoral Artery Occlusion
10.3969/j.issn.0253-9896.2014.08.027
- VernacularTitle:26例TASC(Ⅱ)D型股动脉闭塞腔内治疗临床分析
- Author:
Cunfa LIU
;
Xiujun ZHANG
;
Shugang YIN
;
Junhai LI
;
Mei HUANG
;
Jianpeng CAO
;
Bing DAI
;
Nan ZHANG
;
Jinkai LI
;
Yonglei WANG
- Publication Type:Journal Article
- Keywords:
femoral artery occlusion;
stent;
silverhawk atherectomy;
viabahn stent
- From:
Tianjin Medical Journal
2014;(8):827-829
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate methods and results of endovascular treatment in TASC (Ⅱ) D-type femoral artery occlusion. Methods From January 2012 to May 2013, 26 cases (26 branches) of superficial femoral artery occlusion with endovascular treatment of TASC (Ⅱ) D-type superficial femoral artery occlusion were retrospectively reviewed. The effi-cacy was evaluated through ABI, CTA, DSA and symptoms improved. Results 26 branches were treated with endovascular methods. Technical success rate was 80.7%(21/26), including 13 branche with stent implantation, 6 branches with Silver-hawk atherectomy and 2 branches with Viabahn stent implantation. All patients were followed up for a mean period of (10.3 ± 1.2)months, primary patency rates at 6 months were 69.2%in stent group, 66.7%in Silverhawk atherectomy group and 100%in Viabahn stent group. Conclusion Endovascular treatment of TASC (Ⅱ) D-type femoral artery occlusion can lead to satisfactory short term patency rates, and Viabahn stent is the latest treatment.